ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Mylan Pharmaceuticals INC.

Official 2024 U.S. DOL Form 5500 summary for Mylan Pharmaceuticals INC. (Mylan Pharmaceuticals INC. 401(k) Defined Contribution Plan · EIN 55-0455423 · PN 005): $41.89M net assets, 81 active participants, and $0.19 per $10,000 (0.19 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorMylan Pharmaceuticals INC.
Filing IdentifierMylan Pharmaceuticals INC. 401(k) Defined Contribution Plan · EIN 55-0455423 · PN 005
Plan Category & State401(k) Defined Contribution (PA)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$41.89M
Active Participants81
Direct Admin Fee Rate$0.19 per $10,000 (0.19 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderBank of America / Merrill
Schedule H Line 4a RemittanceSchedule H Line 4a Late Remittance Reported ($2,150, often administrative timing)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI